Session date: 
10/10/2024 - 12:00pm to 1:00pm
PRESENTATION TITLE
Advancing the Development of Gene Therapy for Rare Diseases  
 
SPEAKER
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research (CBER)
Food and Drug Administration (FDA)
 
LEARNING OBJECTIVES
  • Review the gene therapies that are approved in the United States
  • Describe the promise of genome editing technology applied to the treatment of rare diseases
  • Describe how platform technologies provisions may apply to genome editing

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
Peter Marks, PhD (speaker)
Additional presenter: 
Denise Dupras, MD, PhD (moderator)
Support location: 
Minnesota

Please login or register to take this course.
Support location: 
Minnesota